Gilead Sciences (GILD) Acquisitions (2011 - 2026)

Gilead Sciences (GILD) has reported Acquisitions for 10 consecutive years, with $109.0 million the latest figure, recorded in Q1 2026.

• Acquisitions for Q1 2026 came in at $109.0 million, down 60.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $906.0 million (down 15.33% YoY), and the FY2025 annual result was $1.1 billion, down 77.89% from the prior year.
• Acquisitions was $109.0 million for Q1 2026 at Gilead Sciences, down from $609.0 million in the prior quarter.
• Over five years, Acquisitions peaked at $4.0 billion in Q1 2024 and troughed at $21.0 million in Q2 2025.
• Average Acquisitions over 5 years is $527.5 million, with a median of $273.0 million recorded in 2025.
• The widest YoY moves for Acquisitions: up 712.0% in 2025, down 93.25% in 2025.
• Over 5 years, Acquisitions stood at $218.0 million in 2022, then grew by 27.98% to $279.0 million in 2023, then plunged by 73.12% to $75.0 million in 2024, then surged by 712.0% to $609.0 million in 2025, then plunged by 82.1% to $109.0 million in 2026.
• Per Business Quant data, the three most recent Acquisitions figures were $109.0 million in Q1 2026, $609.0 million in Q4 2025, and $167.0 million in Q3 2025.